Intrinsic Value of S&P & Nasdaq Contact Us

Greenrose Acquisition Corp. GNRSW OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
36/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Greenrose Acquisition Corp. (GNRSW) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The current CEO is Nicole Conboy.

GNRSW has IPO date of 2020-05-11, 91 full-time employees, listed on the Other OTC, a market capitalization of $1.77K.

About Greenrose Acquisition Corp.

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Company Details
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
ExchangeOther OTC
CurrencyUSD
IPO Date2020-05-11
CEONicole Conboy
Employees91
Trading Info
Current Price$0.00
Market Cap$1.77K
52-Week Range1.0E-6-1.0E-6
Beta3,309.14
ETFNo
ADRNo
CUSIP395392111
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message